{"id":46421,"date":"2022-07-21T12:01:57","date_gmt":"2022-07-21T10:01:57","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-biosensors-market-report-2022-2035-biosensing-technologies-in-drug-discovery-operations-to-increase-rd-productivity-researchandmarkets-com\/"},"modified":"2022-07-21T12:01:57","modified_gmt":"2022-07-21T10:01:57","slug":"global-biosensors-market-report-2022-2035-biosensing-technologies-in-drug-discovery-operations-to-increase-rd-productivity-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-biosensors-market-report-2022-2035-biosensing-technologies-in-drug-discovery-operations-to-increase-rd-productivity-researchandmarkets-com\/","title":{"rendered":"Global Biosensors Market Report 2022-2035: Biosensing Technologies in Drug Discovery Operations to Increase R&D Productivity – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “Biosensors Market: Focus on Drug Discovery and Development – Distribution by Type of Biosensor, Type of End User and Key Geographies – Industry Trends and Global Forecasts, 2022-2035”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nAt present, various types of biosensors, including optical biosensors, electrochemical biosensors, thermal biosensors and others, are being deployed across different steps of drug discovery, such as disease modelling, target identification\/validation, lead identification, lead optimization and other applications.\n<\/p>\n

\nThe use of biosensing technologies in drug discovery operations is expected to improve the overall R&D productivity by enabling accurate screening and identification of lead drug compounds. Currently, more than 80 biosensors are available in the market \/ being developed by various industry stakeholders for drug discovery and development purposes.\n<\/p>\n

\nFurther, over USD 1.2 billion has been invested in this market by both private and public sector investors, in the last five years. Interestingly, close to 50% of the aforementioned amount was invested in the last two years, reflecting the increasing interest of stakeholders in this domain.\n<\/p>\n

\nIt is also worth highlighting that over 370 patents related to biosensors in drug discovery have been filed\/granted, highlighting the continuous pace of innovation in this field. Considering the active initiatives being undertaken by players in this domain, we are led to believe that the opportunity for stakeholders in this niche, but upcoming, industry is likely to grow at a commendable pace in the foreseen future.\n<\/p>\n

\nScope of the Report<\/strong>\n<\/p>\n

\nThe”Biosensors Market: Focus on Drug Discovery and Development – Distribution by Type of Biosensor (Optical, Electrochemical, Thermal and Others), Type of End User (Academic and Research Institutes and Industry Players) and Key Geographies (North America, Europe, Asia Pacific, Latin America, Middle East and North Africa, and Rest of the World) – Industry Trends and Global Forecasts, 2022-2035″report features an extensive study of the current market landscape and future potential of biosensors in drug discovery, over the next 13 years. The study features an in-depth analysis of key drivers and trends related to this domain. Amongst other elements, the report includes:\n<\/p>\n